title: [Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies].
abstract: The WHO classification describes a group of myelodysplastic/myeloproliferative diseases, including a provisional entity, refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis, underlining that is a provisional entity without consensus of belonging to myelodysplastic rather than to myeloproliferative syndromes. The authors report two cases with features of refractory anaemia with excess of ringed sideroblasts and marked thrombocytosis. In the first case, RARS is concomitant with thrombocytosis and fits the WHO criteria for this temporary entity. The second case is a typical RARS, who developed a thrombocytosis after several years and emphasizes that a link, at least progressive, exists between RARS and myeloproliferative disorders. The authors summed up the various situations related to secondary or primary acquired sideroblastic anaemia, likewise to primitive and reactive thrombocytosis. The cases of RARS + marked thrombocytosis reported in the literature are few in number and do not allow to settle between a particular form of myelodysplastic syndrome and a myeloproliferative disorder, a fully justified reason to classify these patients in a temporary group. To date, there is no codified therapy for this disorders.
authors.affiliation: Laboratoire d'hématologie biologique, Upres EA-3863, Angers. JeGerard@chu-angers.fr
authors.forename: J
authors.initials: J
authors.lastname: Gérard
authors.forename: F
authors.initials: F
authors.lastname: Dubois-Galopin
authors.forename: M
authors.initials: M
authors.lastname: Gardembas-Pain
authors.forename: J-B
authors.initials: JB
authors.lastname: Defaux
authors.forename: A
authors.initials: A
authors.lastname: Schmidt-Tanguy
authors.forename: A
authors.initials: A
authors.lastname: Godon
authors.forename: F
authors.initials: F
authors.lastname: Geneviève
authors.forename: O
authors.initials: O
authors.lastname: Blanchet
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
authors.forename: M
authors.initials: M
authors.lastname: Zandecki
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000756:Anemia, Sideroblastic / Q000145:classification* / Q000150:complications* / Q000473:pathology; D005260:Female; D019337:Hematologic Neoplasms / Q000145:classification / Q000150:complications; D006801:Humans; D008297:Male; D012720:Severity of Illness Index; D013922:Thrombocytosis / Q000150:complications* / Q000473:pathology; D014944:World Health Organization